Thomas C Thomas

Title: Thomas C Thomas: Innovator in the Treatment of Inflammatory Diseases

Introduction

Thomas C Thomas is a notable inventor based in the United States. He has made significant contributions to the field of medicine, particularly in the treatment of glomerulonephritis and other inflammatory diseases. His innovative approaches have the potential to improve patient outcomes and advance therapeutic options.

Latest Patents

Thomas C Thomas holds a patent titled "Methods And Compositions For The Treatment Of Glomerulonephritis And Other Inflammatory Diseases." This patent discloses the use of anti-C5 antibodies, including monoclonal antibodies, to treat glomerulonephritis (GN). The administration of these antibodies at low dosage levels has been found to significantly reduce glomerular inflammation and enlargement, along with other pathological conditions associated with GN. Additionally, the patent introduces novel anti-C5 antibodies and anti-C5 antibody-encoding nucleic acid molecules, which are useful in treating GN and other inflammatory conditions involving pathological activation of the complement system.

Career Highlights

Thomas C Thomas is currently associated with Alexion Pharmaceuticals, Inc., where he continues to work on innovative treatments for inflammatory diseases. His research and development efforts are focused on creating effective therapies that can address unmet medical needs.

Collaborations

Some of his notable coworkers include Mark J Evans and Louis A Matis, who collaborate with him in advancing research and development in the field of inflammatory diseases.

Conclusion

Thomas C Thomas is a dedicated inventor whose work in the treatment of glomerulonephritis and other inflammatory diseases showcases his commitment to improving healthcare. His contributions through innovative patents and collaboration with esteemed colleagues highlight the importance of research in developing effective medical treatments.